Exploring Metformin as the Potential Oral Antidiabetic of Choice for Type II Diabetes Mellitus with Wound Comorbid: A Case-based Literature Review

Main Article Content

Almira Talitha Ulima
Ahmad Fawzy

Abstract

Diabetes is a metabolic disease characterized by hyperglycemia caused by a disruption in insulin secretion, insulin function, or both. An individual with diabetes have a greater likelihood to develop chronic non-healing wounds, and if untreated, various chronic complications are associated with psychiatric stress and depression. In diabetic wounds, the inflammatory phase becomes persistent and excessive with impaired cell proliferation and greater risk of infection. Several studies have shown that metformin has potential effect for diabetic wound healing. Here, we reported a case of diabetic wound in East Jangkat, a rural area in Indonesia, with premorbid type 2 diabetes mellitus and obesity class II with a deeper discussion about the potential effect of metformin for wound healing in diabetic ulcers.

Article Details

How to Cite
Almira Talitha Ulima, & Fawzy, A. . (2023). Exploring Metformin as the Potential Oral Antidiabetic of Choice for Type II Diabetes Mellitus with Wound Comorbid: A Case-based Literature Review. International Journal of Medical Science and Clinical Research Studies, 3(3), 530–540. https://doi.org/10.47191/ijmscrs/v3-i3-38
Section
Articles

References

I. Liwang, Ferry, dkk. 2020. Kapita Selekta Kedokteran Jilid 2 Edisi ke-5 (Edisi ke-5). Depok: Media Aesculapius Fak. Kedokteran UI WHO. 2023. Diabetes. https://www.who.int/health-topics/diabetes, Accessed 20th Feb 2023

II. IDF Diabetes Atlas. 10th ed International Diabetes Federation Brussels, Belgium, International Diabetes Federation (2021)

https://www.diabetesatlas.org/en/, Accessed 20th Feb 2023

III. IDF Diabetes Atlas. Diabetes in Western Pacific – 2021 Factsheet. International Diabetes Federation (2021) https://www.diabetesatlas.org/en/, Accessed 20th Feb 2023.

IV. Indonesia profile. Institute for Health Metrics and Evaluation. http://www.healthdata.org/indonesia, Accessed 20th Feb 2023

V. Eming SA, et al. Wound repair and regeneration: Mechanisms, signaling, and translation. Sci Transl Med. 2014; 6(265):265sr266.

VI. Patel, et al. Mechanistic insight into diabetic wounds: Pathogenesis, molecular targets, and treatment strategies to pace wound healing, Biomedicine & Pharmacotherapy. 2010; 112 https://doi.org/10.1016/j.biopha.2019.108615.

VII. Chung KC, et al. Grabb and Smith's plastic surgery. 8th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2013

VIII. Brown, D.L, et al. Differential expression and localization of insulin-like growth factors I and II in cutaneous wounds of diabetic and nondiabetic mice. Am. J. Pathol. 1997; 151: 715–724.

IX. Roberts, A.B. Transforming growth factor-beta: Activity and efficacy in animal models of wound healing. Wound Repair Regen. 1995; 3: 408–418.

X. Seitz, O, et al. Wound healing in mice with high-fat diet- or ob gene-induced diabetes-obesity syndromes: A comparative study. Exp. Diabetes Res. 2010, 2010, 476969

XI. Wetzler, C, et al. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: Prolonged persistence of neutrophils and macrophages during the late phase of repair. J. Invest. Dermatol. 2000; 115: 245–253.

XII. Triggle et al. Metformin: Is it a drug for all reasons and diseases?, Metabolism. 2022; 133 https://doi.org/10.1016/j.metabol.2022.155223

XIII. Bailey, C.J. Metformin: historical overview. Diabetologia. 2017; 60: 1566–1576. https://doi.org/10.1007/s00125-017-4318-z

XIV. Han et al. Metformin accelerates wound healing in type 2 diabetic db/db mice. MOLECULAR MEDICINE REPORTS. 2017; 16: 8691-8698

XV. Chen LL, et al. Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients. Endocrine. 2010; 38: 266 275.

XVI. Spampinato, et al. The Treatment of Impaired Wound Healing in Diabetes: Looking among Old Drugs. Pharmaceuticals. 2020; 13 (60) doi:10.3390/ph13040060

XVII. Lobmann, R, et al. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing. J. Diabetes Complicat. 2006; 20: 329–335.

XVIII. Liu, Y, et al. Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care. 2009; 32: 117–119.

XIX. Semenza, G.L. HIF-1: Mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 2000; 88: 1474–1480.

XX. Khanna, S, et al. Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS ONE. 2010; 5: e9539.

XXI. Blakytny R. and Jude E: The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med 2006; 23: 594.

XXII. Pence BD, Woods JA. Exercise, Obesity, and Cutaneous Wound Healing: Evidence from Rodent and Human Studies. Adv Wound Care (New Rochelle). 2014 Jan 1;3(1):71-79. doi: 10.1089/wound.2012.0377.

XXIII. Oh J, et al. The Role of Adiponectin in the Skin. Biomolecules & Therapeutics 2022;30:221-231. https://doi.org/10.4062/biomolther.2021.089

XXIV. Pierpont YN, et al. Obesity and surgical wound healing: a current review. ISRN Obes. 2014 Feb 20;2014:638936. doi: 10.1155/2014/638936.

XXV. Xie HH, et al. GTP cyclohydrolase I/BH4 pathway protects EPCs via suppressing oxidative stress and thrombospondin 1 in salt sensi¬tive hypertension. Hypertension. 2010. 56: 1137 1144.

XXVI. Silva JMTS, et al. Factors associated with foot ulceration of people with diabetes mellitus living in rural areas. Rev Gaúcha Enferm. 2017;38(3): e68767. doi: http://dx.doi.org/10.1590/1983- 1447. 2017.03.68767.

XXVII. Haradanahalli RS et al. Personal hygiene practices and related skin diseases among primary school children of urban poor locality. Int J Community Med Public Health. 2019 Jun;6(6):2526-2532

XXVIII. Karmakar A, et al. A study on superficial skin infection and their risk factors among rural population of West Bengal. J Datta Meghe Inst Med Sci Univ 2018;13:20-4.

XXIX. Boyle, et al. Drugs for diabetes: part 1 Metformin. Br J Cardiol 2010;17:231–4

XXX. Hassan KM, et al. Healing the chronic wounds in diabetes using old drugs. Int J Community Med Public Health. 2020 Sep. 25 ;7(10):4185-8. Available from: https://www.ijcmph.com/index.php/ijcmph/article/view/7051

XXXI. El Gazaerly, et al. Effect of transforming growth factor Beta 1 on wound healing in induced diabetic rats. Int. J. Health Sci. 2013; 7: 160–172.

XXXII. Bagheri, et al. Combined effects of metformin and photobiomodulation improve the proliferation phase of wound healing in type 2 diabetic rats. Biomed. Pharmacother. 2020; 123: 109776.

XXXIII. Du F, et al. Metformin coordinates with mesenchymal cells to promote VEGF-mediated angiogenesis in diabetic wound healing through Akt/mTOR activation. Metabolism. 2023 Mar;140:155398.

doi: 10.1016/j.metabol.2023.155398.

XXXIV. Lee J, Hong EM, Kim JH, et al. Metformin induces apoptosis and inhibits proliferation through the AMP-activated protein kinase and insulin-like growth factor 1 receptor pathways in the bile duct cancer cells. J Cancer. 2019;10(7):1734–1744. doi:10.7150/jca.26380

XXXV. Yu et al. Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice. Cardiovasc Diabetol. 2016; 15:88

XXXVI. Lamiaa M. Shawky et al. Stem cells and metformin synergistically promote healing in experimentally induced cutaneous wound injury in diabetic rats. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA. 2019; 57(3): 127–138

XXXVII. Ochoa Gonzalez F, et al. Metformin induces cell cycle arrest, reduced proliferation, wound healing impairment in vivo and is associated to clinical outcomes in diabetic foot ulcer patients. PLoS One. 2016: 11(7): e0150900.

XXXVIII. Olufsen MS, et al. Blood pressure and blood flow variation during postural change from sitting to standing: model development and validation. J Appl Physiol (1985). 2005 Oct;99(4):1523-37. doi: 10.1152/japplphysiol.00177.2005

XXXIX. Tuttolomondo A, Maida C, Pinto A. Diabetic foot syndrome: Immune-inflammatory features as possible cardiovascular markers in diabetes. World J Orthop. 2015 Jan 18;6(1):62-76.

doi: 10.5312/wjo.v6.i1.62.

XL. Wright RB. The Management of Gravitational Ulcer [dissertation]. Scotland (AK): University of Glasgow; 1952

XLI. Lancerotto L, Orgill DP. Mechanoregulation of Angiogenesis in Wound Healing. Adv Wound Care (New Rochelle). 2014 Oct 1;3(10):626-634. doi: 10.1089/wound.2013.0491.

Most read articles by the same author(s)

<< < 1 2 3 4 > >>